跳至主要内容
临床试验/ACTRN12617000792325
ACTRN12617000792325进行中(未招募)未知

A Randomised Controlled Trial Evaluating the Efficacy of Multidomain Dementia Risk Reduction for Cognitive Decline (BBL-CD)

Centre for Research on Ageing, Health and Wellbeing (The Australian National University)0 个研究点目标入组 120 人开始时间: 2017年5月30日最近更新:
适应症

试验速览

阶段
未知
状态
进行中(未招募)
发起方
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Prevention
盲法
Blinded (masking used)

入排标准

年龄范围
65 Years 至 o limit(—)
性别
All

入选标准

  • Living in the Australian Capital Territory or Queanbeyan, New South Wales;
  • -Aged 65 years or over;
  • -Have internet access, a computer at home and sufficient English language skills;
  • -Prepared to make lifestyle changes to improve their health.
  • -Have a medical diagnosis of mild cognitive impairment OR meet the Jessen et al. (2014) criteria for subjective cognitive decline (clinically normal on objective assessment, self/informant reported decline, decline not better accounted for by major medical, neurological or psychiatric diagnosis)

排除标准

  • -Currently participating in any lifestyle change interventions
  • -Diagnosis of Alzheimer's disease or another form of dementia*
  • -Major mental, neurological or physical problems which would prevent them from taking part in a lifestyle change program.
  • *(People may have a diagnosis of mild cognitive impairment, but not dementia).

研究者

发起方
Centre for Research on Ageing, Health and Wellbeing (The Australian National University)

相似试验